Citizens National Bank Trust Department’s Bristol-Myers Squibb BMY Stock Holding History

Citizens National Bank Trust Department’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Sell	26,349 -25	-0.1%	-$1.44K	0.22%	96
2026 Q1	$1.6M	Buy	26,374 +1,359	+5%	+$79.2K	0.27%	89
2025 Q4	$1.35M	Sell	25,015 -600	-2%	-$28.9K	0.23%	99
2025 Q3	$1.16M	Hold	25,615	–	–	0.21%	105
2025 Q2	$1.19M	Sell	25,615 -100	-0.4%	-$4.91K	0.24%	99
2025 Q1	$1.57M	Hold	25,715	–	–	0.34%	80
2024 Q4	$1.45M	Hold	25,715	–	–	0.31%	82
2024 Q3	$1.33M	Sell	25,715 -40	-0.2%	-$1.88K	0.28%	89
2024 Q2	$1.07M	Sell	25,755 -150	-0.6%	-$6.71K	0.24%	95
2024 Q1	$1.4M	Sell	25,905 -2,000	-7%	-$102K	0.33%	81
2023 Q4	$1.43M	Sell	27,905 -240	-0.9%	-$12.6K	0.36%	75
2023 Q3	$1.63M	Sell	28,145 -9,200	-25%	-$564K	0.45%	66
2023 Q2	$2.39M	Sell	37,345 -5,895	-14%	-$395K	0.63%	50
2023 Q1	$3M	Sell	43,240 -75	-0.2%	-$5.29K	0.83%	37
2022 Q4	$3.12M	Sell	43,315 -56	-0.1%	-$4.22K	0.88%	38
2022 Q3	$3.08M	Buy	43,371 +3,145	+8%	+$228K	0.95%	32
2022 Q2	$3.1M	Buy	40,226 +18,724	+87%	+$1.43M	0.89%	34
2022 Q1	$1.62M	Buy	21,502 +190	+0.9%	+$12.8K	0.65%	54
2021 Q4	$1.33M	Sell	21,312 -21,404	-50%	-$1.26M	0.5%	65
2021 Q3	$2.53M	Buy	42,716 +5,551	+15%	+$366K	0.72%	50
2021 Q2	$2.48M	Buy	37,165 +4,400	+13%	+$287K	0.71%	48
2021 Q1	$2.07M	Hold	32,765	–	–	0.63%	55
2020 Q4	$2.03M	Hold	32,765	–	–	0.67%	54
2020 Q3	$1.98M	Hold	32,765	–	–	0.77%	49
2020 Q2	$1.93M	Hold	32,765	–	–	0.82%	47
2020 Q1	$1.83M	Buy	+32,765	New	+$2M	0.97%	41

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citizens National Bank Trust Department's BMY Position: Q2 2026 in Review

Citizens National Bank Trust Department reduced its Bristol-Myers Squibb (BMY) stake by 0.09% in Q2 2026, selling an estimated $1.44K and leaving 26,349 shares worth $1.52M. The position accounts for 0.22% of the portfolio, ranked #96.

Citizens National Bank Trust Department first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.12M in Q4 2022. 1,607 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Citizens National Bank Trust Department held 26,349 shares of Bristol-Myers Squibb worth $1.52M as of Q2 2026.
Citizens National Bank Trust Department sold 25 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.44K.
Bristol-Myers Squibb made up 0.22% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #96 holding.
Citizens National Bank Trust Department first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
Citizens National Bank Trust Department's Bristol-Myers Squibb position peaked at $3.12M in Q4 2022.
1,607 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.